Total Payments
$2,539
2023 Payments
$101.60
Companies
27
Transactions
92
Medicare Patients
5,564
Medicare Billing
$725,874
Payment Breakdown by Category
Food & Beverage$2,513 (99.0%)
Education$26.45 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,513 | 90 | 99.0% |
| Education | $26.45 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $506.00 | 16 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $484.45 | 12 | $0 (2019) |
| Clovis Oncology, Inc. | $309.54 | 11 | $0 (2020) |
| GlaxoSmithKline, LLC. | $261.25 | 3 | $0 (2022) |
| Merck Sharp & Dohme LLC | $184.50 | 6 | $0 (2022) |
| Eisai Inc. | $170.90 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $105.54 | 6 | $0 (2019) |
| Amgen Inc. | $64.87 | 4 | $0 (2019) |
| Helsinn Therapeutics (U.S.), Inc. | $52.99 | 3 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $38.66 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $101.60 | 1 | Eisai Inc. ($101.60) |
| 2022 | $373.37 | 3 | GlaxoSmithKline, LLC. ($250.00) |
| 2021 | $33.02 | 1 | Myriad Genetic Laboratories, Inc. ($33.02) |
| 2020 | $78.33 | 4 | GENZYME CORPORATION ($27.69) |
| 2019 | $645.65 | 26 | AstraZeneca Pharmaceuticals LP ($185.96) |
| 2018 | $711.42 | 31 | TESARO, Inc. ($218.35) |
| 2017 | $595.58 | 26 | TESARO, Inc. ($176.26) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $101.60 | General |
| Category: Oncology | ||||||
| 08/18/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $123.37 | General |
| Category: ONCOLOGY | ||||||
| 05/25/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: ONCOLOGY | ||||||
| 05/12/2021 | Myriad Genetic Laboratories, Inc. | myChoice CDx (Device) | Food and Beverage | Cash or cash equivalent | $33.02 | General |
| Category: Tumor DNA Genetic Oncology Analysis | ||||||
| 11/19/2020 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Oncology | ||||||
| 03/16/2020 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Oncology | ||||||
| 02/03/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $19.55 | General |
| Category: Oncology | ||||||
| 01/14/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar, Vitrakvi | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Oncology | ||||||
| 12/19/2019 | Kyowa Kirin, Inc. | POTELIGEO (Drug), SANCUSO | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: MONOCLONAL ANTIBODY | ||||||
| 12/16/2019 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $16.25 | General |
| 12/05/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Oncology | ||||||
| 11/21/2019 | Lexicon Pharmaceuticals, Inc. | Xermelo (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Carcinoid Syndrome Diarrhea | ||||||
| 11/15/2019 | Mylan Institutional Inc. | Fulphila (Biological), Ogivri | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Oncology | ||||||
| 11/08/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $13.84 | General |
| Category: Oncology | ||||||
| 11/07/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2019 | Secura Bio, Inc. | FARYDAK (Drug), FARYDAK, FARYDAK | Food and Beverage | Cash or cash equivalent | $10.57 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 10/02/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: Oncology | ||||||
| 09/23/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2019 | Helsinn Therapeutics (U.S.), Inc. | AKYNZEO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 129 | 182 | $36,960 | $9,701 |
| 2022 | 37 | 1,510 | 40,627 | $605,716 | $168,949 |
| 2021 | 39 | 1,875 | 52,283 | $686,107 | $199,052 |
| 2020 | 42 | 2,050 | 44,728 | $1.1M | $348,172 |
Total Patients
5,564
Total Services
137,820
Medicare Billing
$725,874
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 40 | 70 | $16,240 | $4,881 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 89 | 112 | $20,720 | $4,820 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 336 | 786 | $150,126 | $50,352 | 33.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 26 | 248 | $73,656 | $25,053 | 34.0% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2022 | 52 | 100 | $63,600 | $15,674 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 155 | $42,005 | $15,176 | 36.1% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 13 | 13 | $24,882 | $9,313 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $13,689 | $4,959 | 36.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 76 | 460 | $23,000 | $4,800 | 20.9% |
| 86304 | Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Office | 2022 | 43 | 224 | $22,400 | $4,607 | 20.6% |
| 71260 | Ct scan of chest with contrast | Office | 2022 | 45 | 94 | $57,622 | $4,449 | 7.7% |
| 77067 | Screening mammography | Office | 2022 | 35 | 35 | $10,500 | $4,361 | 41.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 78 | 475 | $13,775 | $3,646 | 26.5% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 13 | 63 | $9,072 | $3,213 | 35.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 23 | 253 | $11,132 | $3,029 | 27.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 76 | 76 | $5,320 | $2,890 | 54.3% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2022 | 20 | 141 | $6,909 | $2,186 | 31.6% |
| J9267 | Injection, paclitaxel, 1 mg | Office | 2022 | 15 | 21,167 | $10,584 | $1,998 | 18.9% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 35 | 35 | $3,990 | $1,799 | 45.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 11 | 76 | $5,548 | $1,691 | 30.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 107 | 555 | $6,105 | $1,645 | 27.0% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2022 | 11 | 16 | $6,000 | $1,318 | 22.0% |
| J9045 | Injection, carboplatin, 50 mg | Office | 2022 | 15 | 487 | $4,870 | $1,053 | 21.6% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2022 | 53 | 9,575 | $19,150 | $890.81 | 4.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,574 | $876.34 | 34.0% |
About Dr. Diane Semer, MD
Dr. Diane Semer, MD is a Gynecologic Oncology healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245234004.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diane Semer, MD has received a total of $2,539 in payments from pharmaceutical and medical device companies, with $101.60 received in 2023. These payments were reported across 92 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,513).
As a Medicare-enrolled provider, Semer has provided services to 5,564 Medicare beneficiaries, totaling 137,820 services with total Medicare billing of $725,874. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location Greenville, NC
- Active Since 06/09/2005
- Last Updated 10/09/2014
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1245234004
Products in Payments
- ZEJULA (Drug) $717.94
- Rubraca (Drug) $309.54
- LYNPARZA (Drug) $301.05
- KEYTRUDA (Biological) $172.71
- Lenvima (Drug) $151.20
- FASLODEX (Drug) $111.89
- AKYNZEO (Drug) $52.99
- VARUBI (Drug) $49.31
- TAGRISSO (Drug) $45.06
- ZYTIGA (Drug) $41.92
- Stivarga (Drug) $38.66
- NINLARO (Drug) $38.36
- Abraxane (Drug) $33.99
- DARZALEX (Biological) $33.92
- myChoice CDx (Device) $33.02
- Kyprolis (Biological) $32.16
- Erleada (Drug) $29.70
- JEVTANA (Drug) $27.69
- Xermelo (Drug) $26.96
- Bavencio (Biological) $25.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Greenville
Jeffrey Elder, Md, MD
Gynecologic Oncology — Payments: $26,045
Gynecologic Oncology $26,045
Larry Puls, M.d, M.D
Gynecologic Oncology — Payments: $4,688
Gynecologic Oncology $4,688
Jhalak Dholakia, Md, MD
Gynecologic Oncology — Payments: $866.11
Gynecologic Oncology $866.11
Michelle Ertel, M.d, M.D
Gynecologic Oncology — Payments: $345.42
Gynecologic Oncology $345.42
Donald Wiper, Md, MD
Gynecologic Oncology — Payments: $256.17
Gynecologic Oncology $256.17